Janice Schwartz Publish Article in the International Journal of Cardiology

Janice Schwartz, MD and her colleagues at the FDA investigated age effects on the relationship between apixaban concentrations and anti-Factor Xa activity using data from the pivotal clinical trials of apixaban in patients with atrial fibrillation and found the absence of age effects. The article In Press at the International Journal of Cardiology (and Elsevier Journal) is available free on-line for the next month via Share Link.